阿摩線上測驗
78. 依據 BCLC 2022 update，BCLC B 下列何者錯誤？
(1) The treatment options include LT, TACE and systemic therapy
(2) Compared to conventional TACE, DEB-TACE has higher tumor response
rates and survival
(3) AFP higher than 1,000 ng/dl is currently applied as an exclusion criterion of
LT in BCLC B HCC
(4) "BCLC upon progression"(BCLCp) classifies as BCLCp-B those patients
who present radiological progression due to growth of existing nodules
(≥20%) or new intrahepatic sites but are still within BCLC-B
(A) (3)
(B) (2)
(C) (2)＋(3)
(D) (3)＋(4)
(E) (1)＋(3)
(1) The treatment options include LT, TACE and systemic therapy
(2) Compared to conventional TACE, DEB-TACE has higher tumor response
rates and survival
(3) AFP higher than 1,000 ng/dl is currently applied as an exclusion criterion of
LT in BCLC B HCC
(4) "BCLC upon progression"(BCLCp) classifies as BCLCp-B those patients
who present radiological progression due to growth of existing nodules
(≥20%) or new intrahepatic sites but are still within BCLC-B
(A) (3)
(B) (2)
(C) (2)＋(3)
(D) (3)＋(4)
(E) (1)＋(3)
答案：登入後查看
統計： A(0), B(4), C(1), D(0), E(0) #3588534
統計： A(0), B(4), C(1), D(0), E(0) #3588534
